Navigation Links
Golub Capital Provides Debt Financing to Support the Acquisition of Network Express, Inc., by Ace Expediters, Inc.
Date:3/30/2009

NEW YORK, March 30 /PRNewswire/ -- Golub Capital today announced that it has provided a $27.5 million senior credit facility and equity to support the acquisition of Network Express, Inc., by Ace Expediters, Inc., a portfolio company of Atlantic Street Capital.

The combination of Ace Expediters, Inc., (which includes Ace Expediters and Express Courier, d/b/a Medifleet) and Network Express, Inc., creates the leading dedicated route logistics provider in the Eastern United States. The company provides time-critical, reliable delivery solutions for its clients that include companies in the retail auto aftermarket, long-term care pharmaceutical and medical testing laboratory end markets.

At Network Express, medical distribution services have expanded over the years to include some of the most sensitive medical deliveries such as delivering to nursing facilities, pharmaceutical wholesalers, and medical laboratories requiring specimen retrieval. In 2003, Network Express was inducted into the prestigious Inc. 500, by Inc. Magazine, as one of the fastest growing privately held companies in America.

"We are very pleased to support Atlantic Capital on growing Ace Expediters' already thriving platform. Ace's business model and financial performance is on point for what we are seeking today," says Golub Capital Senior Managing Director Andy Steuerman. "However, it is still a very challenging time to get a transaction across the finish line. This transaction utilized our knowledge of the logistics industry to complete this deal in a timely manner."

This is Golub Capital's first deal with Atlantic Street Capital.

"We felt comfortable with Golub Capital because they really understood the sector and provided a full solution in a market where very few parties are lending. After working with the Golub team on closing this deal, we are confident that Golub Capital will help us grow the company as we ca
'/>"/>

SOURCE Golub Capital
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed
2. ReGear Life Sciences Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc.
3. Capital BlueCross Reaches Out to Families of Uninsured Children
4. BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches
5. Elekta Finds New Interest in Leasing Solutions as Hospitals Debate Capital Purchases
6. NASDAQ Panel Grants Extension to DATATRAK for Continued Listing on the NASDAQ Capital Market
7. Abaxis, Inc. to Attend Lazard Capital Markets Medical Technologies Conference
8. Wyclef Jean and Miri Ben-Ari to Lead Phoenix House Tribute to Lisa Ellis of Fireman Capital Partners and Carnival House Recordings
9. InstaMed Announces Osage Partners and Ashby Point Capital Have Joined Existing Investors in $6 Million Growth Equity Financing
10. LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nations Capital
11. Amgen to Present at the Barclays Capital Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... News) -- Most professional football players who have shoulder ... a new study finds. Shoulder instability is a ... return after surgery to fix the problem has been ... included 60 players who had shoulder stabilization surgery. Ninety ... to play, defined as playing in at least one ...
(Date:7/10/2014)... 10, 2014 (HealthDay News) -- Teens who are sensitive ... likely to develop emotional symptoms such as anxiety and ... as these that may exacerbate issues teens experience after ... and in making decisions about when to return to ... these athletes," study authors Lisa Koehl and Dong Han, ...
(Date:7/10/2014)... 2014 (HealthDay News) -- Men who have a vasectomy ... a new study suggests. But the risk is ... involved with the study said more research is needed ... For the study, Harvard researchers analyzed data from ... 24 years, starting in 1986. During that time, 6,023 ...
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July 10, 2014 ... use of calorie information on menus, if it,s available, to ... U.S. study. Women in particular review the menu labeling, ... with the U.S. Centers for Disease Control and Prevention. ... to help choose their meal, compared with just under half ...
(Date:7/10/2014)... Emergency Medical Service (EMS) responders felt better prepared to ... tactical training according to a new study in the ... the first study to specifically examine the EMS provider ... a shooter has not yet been neutralized or working ... such as the Columbine High School shooting, the Virginia ...
Breaking Medicine News(10 mins):Health News:Shoulder Surgery Gets NFL Players Back in the Game 2Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3Health News:Active shooter training increases comfort level of emergency responders 2
... associated with Alzheimer,s and mad cow disease, turns out ... paper published in Nature Chemical Biology , Frederic ... Universiteit Brussel describe that certain mutations of p53, an ... a way that the proteins start to aggregate. This ...
... 29 (HealthDay News) -- Dangerous methicillin-resistant staphylococcus aureus, or MRSA, ... this seasonal increase is more common in children than adults, ... analysis of MRSA cases that occurred at Rhode Island Hospital, ... children,s infections were higher in the third and fourth quarters ...
... application provided by the UK Resuscitation Council performed significantly ... did not, according to a study in the April ... approximately 30,000 people in the UK have an unexpected ... resuscitation research, survival rates for adults suffering a cardiac ...
... that liver transplant recipients who quit smoking have a ... keep smoking. In fact, SRMs were identified in 13.5% ... higher risk of malignancy in this study. Full findings ... Transplantation , a journal of the American Association for ...
... News) -- Death rates among teens and young adults aged 15 ... 4 years in many countries, says a new study that ... of researchers that analyzed the causes and patterns of death among ... 2004 also found that death rates among young males aged 15 ...
... Severely obese men and women who have bariatric surgery may ... much of their pre-surgery risk for experiencing disabling migraines, researchers ... a small study of obese patients with a history of ... roughly 66 pounds by the half-year point following either laparoscopic ...
Cached Medicine News:Health News:Cancer is a p53 protein aggregation disease 2Health News:MRSA Infections May Vary by Season 2Health News:Free phone app helped doctors perform better in simulated cardiac emergency 2Health News:Smoking in combination with immunosuppression poses greater risk for transplant-related carcinoma 2Health News:Death Rates of Children, Young Adults Show Reversal 2Health News:Weight-Loss Surgery May Cut Migraine Pain in Obese Patients 2Health News:Weight-Loss Surgery May Cut Migraine Pain in Obese Patients 3
(Date:1/15/2014)... BOSTON , Jan. 15, 2014 Tegra Medical is ... Mark King as its new Chief Executive Officer.  Mark ... in which he has overseen the company,s four facilities in ... and Costa Rica.  Mr. King joined Tegra Medical in 2012 ...
(Date:1/15/2014)... Inc. (Nasdaq: ECTE ) ("Echo"), a medical ... non-invasive, wireless continuous glucose monitoring system, today announced that ... CEO of Echo Therapeutics, will present at "TEN", Noble ... Mr. Doman will make a corporate presentation to ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... VANCOUVER, April 26, 2007,/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, ... device company, announced that,the two-year data from ... Paclitaxel-Eluting Mesh ("Vascular Wrap(TM)"),will be presented today ... study examined the safety and efficacy of ...
... 26, 2007 /PRNewswire-FirstCall/ --,Australian drug development company ... randomised Phase II clinical,trial in patients with ... compared to irinotecan which is,considered to be ... colorectal,cancer. This announcement is being made at ...
Cached Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 2Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 3Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 4Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 5Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 6Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 7
... CC 527 is an assayed quality control material ... electrolyte, and CO-Oximeter instrumentation. It is for specific ... and hemoglobin fractions (280, 288, and 270) and ... 527 may also be used on the IRMA ...
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens....
Cormet Hip Resurfacing is a conservative treatment for the young, active, high demand patient group which conserves femoral bone, provides anatomical bone loading, eliminates polyethylene and is desi...
For the qualitative detection of igG antibodies specific to Helicobacter pylori in human serum, plasma and whole blood specimens...
Medicine Products: